Popular weight-loss drugs like Wegovy fail to lower obesity-related cancer risks, study finds

Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...
Yahoo

Wegovy vs. Zepbound: Study reveals which is better for weight loss

(NewsNation) — A new study has pitted Wegovy and Zepbound head-to-head in their ability to treat obesity. Published in The New England Journal of Medicine on May 11, the study attempted to ...
AOL

Zepbound More Effective for Weight Loss Than Wegovy, Eli Lilly Trial Shows

Participants who received tirzepatide, the active ingredient in Zepbound, also had greater reductions in waist size and more significant improvements in metabolic risk factors. Tirzepatide’s dual ...
The New York Sun

Zepbound Maker Eli Lilly Reports Patients Achieved Dramatic Weight Loss in Study of Newest Obesity Drug

Some patients dropped out of the trial early because they had lost so much weight.
Healthline

Why Am I Not Losing Weight on Zepbound?

Zepbound (tirzepatide) is a brand-name injection prescribed for weight loss, weight management, and more. You may need to take Zepbound for several months to see the full effects of the drug ...

A better Ozempic? Eli Lilly’s new obesity drug cut weight by 23%, study finds

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...
Psychology Today

Why Healthy Weight Loss Remains a Life-Long Journey

Research is important to us for many reasons. Sometimes, for example, research results in a new treatment (e.g., Alexander Fleming and penicillin), a new idea (e.g., Einstein's theory of relativity), ...

Lilly’s experimental shot cuts body weight by 23% in study

A next-generation obesity shot from Eli Lilly and Co. helped patients lose almost a quarter of their body weight, potentially ...